Pediatric Inflammatory Bowel Disease Clinical Trial

IBD Pediatric Clinical Trial Near Ehrhardt SC

Looking for a new potential treatment option for your child’s rectal bleeding associated with your gastrointestinal disease? Learn about a new failure to thrive.

INDICATION (DISEASE)

about the study

We are looking for 2–17 year olds to join a study to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderate to severe IBD (including associated symptoms such as cramping, perianal fistula, constant need to poop, frequent fevers and/or canker sores), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

  • are 2‒17 years of age
  • have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
  • have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Compensation

Compensation is available.

Enrolling Patients Near

Join the Study

See if you're eligible to participate.

Also Enrolling Patients Near...

Don't Meet the Criteria for this Study?

You could still participate in other studies. Become a Clinically Insider to be added to our database. You’ll be notified ASAP about our future studies that may be right for you.